Comparison of gastric cancer survival after R0 resection in the US and China.
Comparison of gastric cancer survival after R0 resection in the US and China.
复制标题
DOI:
10.1002/jso.25220
复制
发表时间:
2018-11
影响因子:
2.5
通讯作者:
Strong VE
中科院分区:
文献类型:
--
作者:
Li P;Huang CM;Zheng CH;Russo A;Kasbekar P;Brennan MF;Coit DG;Strong VE
Gastric cancer outcomes differ between Asian and Western countries, even when controlling for contributing factors, but whether this difference holds true for China remains inadequately studied. We sought to compare the presentation, treatment, and outcomes of patients with gastric cancer (GC) undergoing curative intent (R0) resection between the U.S. and China, and to ascertain whether geography/ institution is an independent predictor of DSS. Data were analyzed from patients with GC undergoing R0 resection at high-volume cancer centers in the U.S. (Memorial Sloan Kettering Cancer Center [MSKCC], n=1,378) and China (Fujian Medical University Union Hospital [FMUUH], n=4,262) between 2000 and 2014. Factors associated with disease-specific survival (DSS) were examined by multivariate analysis. The 5-year DSS (p < 0.001) for all patients was better at MSKCC than at FMUUH, even among patients not receiving preoperative chemotherapy (p < 0.001), but stratification by sub-stage eliminated this difference (p > 0.05). Factors independently associated with DSS included age, histology, tumor size, T category, N category, gastrectomy type, and preoperative chemotherapy, but not institution. Although the presentation of GC patients between MSKCC and FMUUH differs, survival of patients with curatively resected GC, when matched for clinical stage, is comparable.